Onward Medical Bv Stock Current Ratio
| 63E Stock | 4.47 0.09 2.05% |
ONWARD MEDICAL BV fundamentals help investors to digest information that contributes to ONWARD MEDICAL's financial success or failures. It also enables traders to predict the movement of ONWARD Stock. The fundamental analysis module provides a way to measure ONWARD MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ONWARD MEDICAL stock.
ONWARD |
ONWARD MEDICAL BV Company Current Ratio Analysis
ONWARD MEDICAL's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, ONWARD MEDICAL BV has a Current Ratio of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
ONWARD Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ONWARD MEDICAL's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ONWARD MEDICAL could also be used in its relative valuation, which is a method of valuing ONWARD MEDICAL by comparing valuation metrics of similar companies.ONWARD MEDICAL is currently under evaluation in current ratio category among its peers.
ONWARD Fundamentals
| Return On Equity | -2.89 | |||
| Return On Asset | -0.34 | |||
| Operating Margin | (19.04) % | |||
| Shares Owned By Insiders | 41.37 % | |||
| Shares Owned By Institutions | 39.43 % | |||
| Revenue | 1.78 M | |||
| Gross Profit | (10.58 M) | |||
| EBITDA | (33.44 M) | |||
| Book Value Per Share | 2.28 X | |||
| Earnings Per Share | (3.62) X | |||
| Number Of Employees | 76 | |||
| Market Capitalization | 34.4 M |
About ONWARD MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ONWARD MEDICAL BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ONWARD MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ONWARD MEDICAL BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ONWARD Stock
ONWARD MEDICAL financial ratios help investors to determine whether ONWARD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ONWARD with respect to the benefits of owning ONWARD MEDICAL security.